Scientific Publications: 1998
- Gorny, M, Mascola, J, Israel, Z, Van Cott, T, Williams, C, Balfe, P, Hioe, C, Brodine, S, Burda, S and Zolla-Pazner, S, A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades. AIDS Res Hum Retroviruses 1998. 14: p213-221.
- McCutchan, F, Sanders-Buell, E, Salminen, M, Carr, J and Sheppard, W, Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants. AIDS Res Hum Retroviruses 1998. 14: p329-337.
- Oelrichs, R, Workman, C, Laukkanen, T, McCutchan, F and Deacon, N, A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso. AIDS Res Hum Retroviruses 1998. 14: p1495-1500.
- Beyrer, C, Vancott, T, Peng, N, Artenstein, A, Duriasamy, G, Nagaratnam, M, Saw, T, Hegerich, P, Loomis-Price, L, Hallberg, P, Ettore, C and Nelson, K, HIV type 1 subtypes in Malaysia, determined with serologic assays: 1992-1996. AIDS Res Hum Retroviruses 1998. 14: p1687-1691.
- Perfetto, SP, Malone, JD, Hawkes, C, McCrary, G, August, B, Zhou, S, Garner, R, Dolan, MJ and Brown, AE. CD38 Expression on Cryopreserved CD8+T Cell Predicts HIV Disease Progression. Cytometry, 1998;33:131-137
- Michael, NL. Letter to the editor, Protective Effect of an SDF-1 Variant in HIV Disease. JAMA, 1998;14:1140
- Martin, M, Carrington, M, Dean, M, O'Brien, S, Sheppard, H, Wegner, S and Michael, N, CXCR4 polymorphisms and HIV-1 pathogenesis. J Acquir Immune Defic Syndr Hum Retrovirol 1998. 19: p430-432.
- Mason, C, Kitsiripornchai, S, Markowitz, L, Chanbancherd, P, Supapongse, T, Jugsudee, A, Sirisopana, N, Chuenchitra, C, Torugsa, K, Vancott, T, Michael, R and Nitayaphan, S, Nationwide surveillance of HIV-1 prevalence and subtype in young Thai men. J Acquir Immune Defic Syndr Hum Retrovirol 1998. 19: p165-173.
- Lambert, J, McNamara, J, Katz, S, Fenton, T, Kang, M, Vancott, T, Livingston, R, Hawkins, E, Moye, J, Borkowsky, W, Johnson, D, Yogev, R, Duliege, A, Francis, D, Gershon, A, Wara, D, Martin, N, Levin, M, McSherry, G and Smith, G, Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218). J Acquir Immune Defic Syndr Hum Retrovirol 1998. 19: p451-461.
- Wegner, S, Ehrenberg, P, Chang, G, Dayhoff, D, Sleeker, A and Michael, N, Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1. J Biol Chem 1998. 273: p4754-4760.
- Lew, J, Reichelderfer, P, Fowler, M, Bremer, J, Carrol, R, Cassol, S, Chernoff, D, Coombs, R, Cronin, M, Dickover, R, Fiscus, S, Herman, S, Jackson, B, Kornegay, J, Kovacs, A, McIntosh, K, Meyer, W, Michael, N, Mofenson, L, Moye, J, Quinn, T, Robb, M, Vahey, M, Weiser, B and Yeghiazarian, T, Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol 1998. 36: p1471-1479.
- Mann, D, Garner, R, Dayhoff, D, Cao, K, Fernandez-Vina, M, Davis, C, Aronson, N, Ruiz, N, Birx, D and Michael, N, Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans. J Infect Dis 1998. 178: p1799-1802.
- Horspool, J, Perrin, P, Woodcock, J, Cox, J, King, C, June, C, Harlan, D, St, LD and Lee, K, Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4. J Immunol 1998. 160: p2706-2714.
- Blair, PJ, Riley, JL, Levin, BL, Lee, KP, Craighead, N, Francomano, T, Perfetto, SJ, Gray, GS, Carreno, BM and June. CJ Cutting Edge: CTLA-4 Ligation Deliver a Unique Signal to Resting Human CD4 T Cells That Inhabits Interleukin-2 Secretion but Allows Bd-XL induction1. J Immunol, 1998;160:12-15
- Vancott, T, Kaminski, R, Mascola, J, Kalyanaraman, V, Wassef, N, Alving, C, Ulrich, J, Lowell, G and Birx, D, HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. J Immunol 1998. 160: p2000-2012.
- Loomis-Price, L, Cox, J, Mascola, J, Vancott, T, Michael, N, Fouts, T, Redfield, R, Robb, M, Wahren, B, Sheppard, H and Birx, D, Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection. J Infect Dis 1998. 178: p1306-1316.
- Lynch, J, de, SM, Robb, M, Markowitz, L, Nitayaphan, S, Sapan, C, Mann, D, Birx, D and Cox, J, Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais. J Infect Dis 1998. 178: p1040-1046.
- Clements-Mann, ML, Weinhold, K, Matthews, TJ, Graham, BJ, Gorse, GJ Keefer, MC, McElrath, JM, Hsieh, RA, Mesteckey, J Zolla-Pazner, S, Mascola, J, Schwartz, S, Siliciano, R, Corey, R, and Wright, P. Immune Responses to Human Immunodeficiency Virus (HIV) †ype 1 Induced by Canarypox Expressing HIV-1mn gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults. J Infect Dis, 1998;177:1230-46
- St Louis, D, Gotte, D, Sanders-Buell, E, Ritchey, D, Salminen, M, Carr, J and McCutchan, F, Infectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro. J Virol 1998. 72: p3991-3998.
- Michael, N, Nelson, J, Kewal, RV, Chang, G, O'Brien, S, Mascola, J, Volsky, B, Louder, M, White, G, Littman, D, Swanstrom, R and O'Brien, T, Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol 1998. 72: p6040-6047.
- Langlois, A Desrosiers, RC, Lewis, MG, Kewalramani, VN, Littman, DR, Ying Zhou, J, Manson, K, Wyand, MS, Bolognesi, DP and Montefiori D. Neutralizing Antibodies in Sera from Macaques Immunized with Attenuated Simian Immunodeficiency Virus. J Virol, Aug 1998;72(8):6950-6955
- Stamatos, N, Mascola, J, Kalyanaraman, V, Louder, M, Frampton, L, Birx, D and Vancott T, Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140. J Virol 1998. 72: p9656-9667.
- Frankel, S, Steinman, R, Michael, N, Kim, S, Bhardwaj, N, Pope, M, Louder, M, Ehrenberg, P, Parren, P, Burton, D, Katinger, H, Vancott, T, Robb, M, Birx, D and Mascola, J, Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells. J Virol 1998. 72: p9788-9794.
- Nannis, ED, Schneider, S, Jenkins, PR, Sharp-Breslau, E, Daniell, FD and McKee Jr., KT Human Immunodeficiency Virus (HIV) Educatio and HIV Risk Behavior: A Survey of Rapid Deployment Troops. Military Medicine, 1998;163(1):672
- Mascola, JR, McNeil JR & Birx, DB. Letter to the Editor, Vaccine Reactions. Nature Medicine, July 1998;4(7):746
- Martin, M, Dean, M, Smith, M, Winkler, C, Gerrard, B, Michael, N, Lee, B, Doms, R, Margolick, J, Buchbinder, S, Goedert, J, O'Brien, T, Hilgartner, M, Vlahov, D, O'Brien, S and Carrington, M, Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998. 282: p1907-1911.
- Carr, J, Salminen, M, Albert, J, Sanders-Buell, E, Gotte, D, Birx, D and McCutchan, F, Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology 1998. 247: p22-31.
- Brown, AE and McNeil, JG. HIV vaccine development: a subtype E-specific strategy. Southeast Asian J Trop Med Public Health 1998. 29: p377-382
- Bruce L. Levine, J Cotte, CC Small, RG Carroll, JL Riley, WB Bernstein, Epps DE Vancott, T, RA Hardwick and CH June, Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3/CD28 costimulation. J Hematother 1998. 7: p437-448
- Merlin L. Robb, C Khambaroong and KE Nelson, Studies in Thailand of the vertical transmission of HIV. N Engl J Med 1998. 338: p843-844
- Schubert U, LC Anton, I Bacik, JH Cox, S Bour, JR Bennink, M Orlowski, K Strebel and JW Yewdell, CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J Virol 1998. 72: p2280-2288
- Carr JK, Foley BT, Leitner T, Salminen MO, Korber B, McCutchan F. 1998 Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic. In: Human Retroviruses and AIDS, Los Alamos National Laboratory, Los Alamos, NM.
